Corcept Therapeutics (CORT) Shares Outstanding: 2009-2022
Historic Shares Outstanding for Corcept Therapeutics (CORT) over the last 5 years, with Dec 2022 value amounting to $107.8 million.
- Corcept Therapeutics' Shares Outstanding rose 1.79% to $107.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $107.8 million, marking a year-over-year increase of 1.79%. This contributed to the annual value of $107.8 million for FY2022, which is 1.79% up from last year.
- Corcept Therapeutics' Shares Outstanding amounted to $107.8 million in Q4 2022, which was up 0.21% from $107.6 million recorded in Q3 2022.
- Over the past 5 years, Corcept Therapeutics' Shares Outstanding peaked at $116.7 million during Q4 2020, and registered a low of $105.9 million during Q4 2021.
- Moreover, its 3-year median value for Shares Outstanding was $114.9 million (2020), whereas its average is $112.1 million.
- In the last 5 years, Corcept Therapeutics' Shares Outstanding climbed by 1.91% in 2020 and then declined by 9.25% in 2021.
- Corcept Therapeutics' Shares Outstanding (Quarterly) stood at $115.0 million in 2018, then dropped by 0.42% to $114.5 million in 2019, then climbed by 1.91% to $116.7 million in 2020, then dropped by 9.25% to $105.9 million in 2021, then climbed by 1.79% to $107.8 million in 2022.
- Its Shares Outstanding was $107.8 million in Q4 2022, compared to $107.6 million in Q3 2022 and $106.7 million in Q2 2022.